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Fluid flow regulates E-selectin protein levels in
human endothelial cells by inhibiting translation
Larry W. Kraiss, MD,a,b,c Neal M. Alto, BS,a,c Dan A. Dixon, PhD,b,d Thomas M. McIntyre, PhD,b,f
Andrew S. Weyrich, PhD,b,e and Guy A. Zimmerman, MD,b,e Salt Lake City, Utah
Objective: The purpose of this study was to determine the mechanism with which fluid flow inhibits endothelial E-selectin
expression.
Methods: Cultured human umbilical vein endothelial cells were stimulated with inflammatory agonists (tumor necrosis
factor– [TNF-], interleukin-1, oncostatin M, or phorbol ester) in the presence or absence of fluid flow (peak shear
stress, 12 dynes/cm2) imposed with an orbital shaker. E-selectin expression was assessed with ribonuclease protection
assay, immunoblotting, enzyme-linked immunosorbent assay, or metabolic labeling as appropriate.
Results: All agonists caused human umbilical vein endothelial cells to express E-selectin protein. Fluid flow inhibited
E-selectin protein levels by about 50% in response to TNF- but had no effect on total E-selectin messenger RNA
(mRNA) expression. Flow inhibited E-selectin protein production even after initiation of E-selectin transcription. Flow
did not cause E-selectin to be shed from the cell surface nor was E-selectin degradation accelerated. Although fluid flow
did not reduce total cellular E-selectin mRNA levels in response to TNF-, the amount of E-selectin mRNA present in the
actively translated polysome fraction was markedly attenuated.
Conclusion: These findings indicate that E-selectin expression is subject to translational and transcriptional control. Fluid
mechanical forces can regulate endothelial phenotype by targeting translational control points. (J Vasc Surg 2003;37:161-8.)
Endothelial cells change their phenotype in response to
different environmental conditions, a process that often
requires new protein translation, which in turn may depend
on gene transcription. When exposed to inflammatory cy-
tokines, such as tumor necrosis factor– (TNF-), quies-
cent endothelial cells transition to an activated proinflam-
matory phenotype. They express adhesion molecules and
produce other signaling mediators that serve to attract,
bind, and activate circulating leukocytes to the site of
inflammation.1,2 Located at the interface between the flow-
ing blood and the vessel wall, the endothelium is exposed to
a variety of mechanical forces, including fluid shear stress
along with hydrostatic pressure and circumferential stretch.
These forces also influence endothelial phenotype.3,4 Thus,
in vivo, the net endothelial response to a given humoral
stimulus is likely to be modulated by the coexisting hemo-
dynamic milieu. We therefore reasoned that fluid flow
would influence the endothelial response to an inflamma-
tory stimulus.
The transcriptional regulator nuclear factor–B (NF-  B)
controls expression of many endothelial genes responsive to
inflammatory stimuli, including E-selectin and interleukin-8.
In preliminary studies, we found evidence for an inhibitory
effect of fluid flow on NF-B activation induced by TNF-
and correlated this inhibition with reduced production of
these two inflammatory proteins.5 In this report, we focus on
the mechanisms with which fluid flow regulates E-selectin
protein production. We attempted to link the flow-dependent
inhibition of NF-B and reduced E-selectin production by
showing a similar inhibitory effect of flow on E-selectin mes-
senger RNA (mRNA). On the basis of our initial experi-
ments,5 we predicted that flow-dependent inhibition of
NF-B translocation would have a similar effect on expression
of mRNA transcripts for E-selectin. Unexpectedly, we found
that fluid flow had no effect on total E-selectin mRNA levels
after stimulation with TNF- but that fluid flow did decrease
the amount of E-selectin mRNA associated with polyribo-
somes. Thus, E-selectin synthesis does require induction of
transcription but is also separately influenced by biomechani-
cal (fluid flow) control of translation. These findings highlight
an alternative nontranscriptional mechanism for hemody-
namic regulation of vascular gene expression.
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METHODS
Reagents. Unless otherwise specified, all chemicals
and reagents were purchased from Sigma (St Louis, Mo).
TNF-, interleukin-1, and oncostatin M (OSM) were
obtained from R&D Systems (Minneapolis, Minn).
[35S]methionine and [-32P]uridine triphosphate were
supplied by either Amersham (Piscataway, NJ) or ICN
(Costa Mesa, Calif).
Cell culture. Primary human umbilical vein endothe-
lial cell (HUVEC) cultures were established in 6-well plates
as previously described by our group.6,7 Experiments were
performed with confluent monolayers on the third or
fourth day after plating. Unless otherwise indicated, exper-
iments were performed with cells in complete culture media
containing 20% pooled human serum.7
Application of fluid flow to HUVEC monolayers.
Fluid flow was applied with placement of the HUVEC
monolayers on a benchtop orbital shaker (Bellco Biotech-
nology, Vineland, NJ).6,8-10 Although this technique does
not produce unidirectional laminar shear stress, peak fluid
shear stress at the bottom of the well is estimated as:
max a(2	f )3
where a is the radius of orbital rotation (14 mm),  is the
density of the culture medium (1.0 g/mL),  is the me-
dium viscosity (assumed to be 0.0075 poise), and f is the
frequency of rotation (rps).8 At 200 rpm, the calculated
value for max is approximately 12 dynes/cm
2.
Other investigators and we have found this method to
produce endothelial responses that are similar to those
produced by laminar fluid shear stress with respect to nitric
oxide production10 and activation of intracellular signaling
cascades.6,9 Selected experiments were also performed with
a cone-plate viscometer11,12 to compare the effects of the
two methods of producing flow on E-selectin expression.
Immunoblotting. After experimental treatment, the
HUVECs were placed on ice and extracted with a nonre-
ducing buffer (5% sodium dodecylsulfate [SDS]; 125
mmol/L Tris-HCl, pH 6.8; 2% sucrose; 0.05% bromphe-
nol blue). After centrifugation, equivalent amounts of su-
pernatant (10 
g protein/lane) then were subjected to
SDS–polyacrylamide gel electrophoresis (PAGE). After
electrophoretic transfer to a membrane (Immobilon-P,
Millipore, Bedford, Mass), E-selectin was detected with a
biotinylated monoclonal antihuman E-selectin antibody
(BBA 8, R&D Systems). After rinsing, the bound primary
antibody was detected with a streptavidin-peroxidase con-
jugate (Sigma) and then visualized with enhanced chemi-
luminescence (Amersham).
Ribonuclease protection assay. Total RNA from
HUVECs stimulated with TNF- (10 u/mL) was isolated
with the TRIzol reagent (Gibco BRL, Carlsbad, Calif)
followed by preparation of complementary DNA with re-
verse transcription (M-MuLV RT, Gibco BRL). An E-
selectin probe then was generated with polymerase chain
reaction (PCR) with oligonucleotides corresponding to nts
1361-83 (ACTTCACCTGTGAGGAAGGCTTC) as the
5 3 3 primer and nts 1932-55 (AGGATGGACGCT-
CAATGGCTCTGC) as the 33 5 primer. The E-selectin
PCR product then was cloned into pCR 2.1 (Original TA
Cloning Kit, Invitrogen, Carlsbad, Calif) and transformed
into One Shot cells (Invitrogen). The sense-oriented plas-
mid then was obtained with gel purification after restriction
digest with Hind III. A plasmid template for reduced
glyceraldehyde-phosphate dehydrogenase (pTRI-GAPDH)
suitable for immediate in vitro transcription was obtained
from Ambion (Austin, Tex). The [-32P]uridine triphos-
phate–labeled antisense riboprobes for both E-selectin and
GAPDH then were prepared with in vitro transcription
according to a commercial protocol (PharMingen Ribo-
quant In Vitro Transcription Kit, San Diego, Calif). The
probes were designed so that the undigested E-selectin
probe was 523 nucleotides in length and the protected
fragment was 502 nucleotides long. Corresponding lengths
for the human GAPDH probe were 383 and 316 nucleo-
tides, respectively.
After experimental treatment, total cellular RNA or
polysome-associated RNA (see subsequent) was isolated
from HUVEC with the TRIzol reagent. The hybridization
and digestion reactions were performed with Ambion’s
Direct Protect Kit. Briefly, after determination of the spe-
cific activity of the E-selectin and GAPDH riboprobes,
equal amounts of each probe (6.43  105 cpm) were
coincubated overnight at 37° C with 10 _g of RNA/
sample. After hybridization, appropriate controls and the
samples were treated with ribonuclease for 30 minutes at
37° C. The samples then were separated on a 6% polyacryl-
amide/7 mol/L urea sequencing gel and analyzed with
autoradiography after drying.
E-selectin enzyme-linked immunosorbent assay.
After stimulation with TNF- in the presence or absence of
fluid flow, culture medium was collected and concentrated
with Centricon (Millipore, Bedford, Mass) centrifugation
tubes (30 kD cutoff). Whole cell HUVEC lysates were
prepared in parallel with RIPA buffer (Santa Cruz Biotech-
nology, Santa Cruz, Calif). Samples then were analyzed
with an enzyme-linked immunosorbent assay capable of
detecting soluble E-selectin in concentrations as low as 0.1
ng/mL (R&D Systems).
These experiments were performed in parallel in the
presence or absence of 20% pooled human serum. This
serum preparation contained 45  11 ng/mL soluble
E-selectin and accounted for virtually all of the E-selectin
recovered from the culture media when HUVEC were
treated with TNF-. However, the presence or absence of
serum had no effect on the amount of E-selectin recovered
from the HUVEC lysates after TNF- treatment. Thus, to
eliminate confusion with data containing high background
amounts of E-selectin in serum-containing culture media,
the serum-free experiments are presented.
Metabolic labeling of HUVEC with [35S]methi-
onine. HUVEC were depleted of methionine overnight
and then subjected to experimental manipulation. At the
onset of each experiment, HUVECs were repleted with
[35S]methionine (0.1-1.0  106 Bq/mL).
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Fig 1. Stimulated E-selectin protein expression with HUVEC is reduced by fluid flow. Confluent HUVEC mono-
layers were stimulated with indicated agonist and incubated for 4 hours under stationary conditions or on orbital shaker
to generate fluid flow (200 rpm). Equal aliquots of cell lysates (10 
g protein/lane) then were analyzed with Western
blotting (see Methods). A, Effect of flow on E-selectin expression in response to TNF- (10 u/mL), interleukin-1 (1
u/mL), OSM (4.5 nmol/L), and phorbol 12-myristate 13-acetate (10 nmol/L). B, Effect of flow on E-selectin
expression in response to increasing concentrations of TNF-. C, Graphic and tabular display of effect of fluid flow on
TNF-–induced E-selectin expression. Data are summary of densitometric analyses of all E-selectin immunoblots
produced for this study. D, Time course of fluid flow effect on E-selectin expression in response to TNF- (10 u/mL).
Three panels represent different exposure times to highlight differences in E-selectin signal between static and flow.
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For the assessment of overall protein synthesis in re-
sponse to flow, HUVEC were labeled under static or fluid
flow conditions for 4 hours and lysed in Laemmli buffer and
the proteins were resolved with SDS-PAGE. For the exper-
iments designed to specifically label E-selectin, HUVECs
were stimulated with TNF- (100 u/mL) under static flow
conditions in the presence of [35S]methionine (1  106
Bq/mL) to induce synthesis of radiolabeled E-selectin.
Four hours later, the medium was changed and a 4-hour or
6-hour chase was performed in the presence or absence of
fluid flow. HUVECs then were lysed in ice-cold RIPA
buffer, and labeled E-selectin was immunoprecipitated with
an anti–E-selectin antibody (BBA 16, R&D Systems). Im-
mune complexes were collected with agarose conjugate
protein A beads (Santa Cruz Biotechnology) and resolved
with SDS-PAGE. The dried gel was analyzed with autora-
diography.
Polysome preparation. The technique for isolation
of polysome pellets was adapted from Bommer et al.13 After
experimental treatment, HUVEC cultures were rinsed with
ice-cold phosphate-buffered saline solution and then
scraped under ice-cold lysis buffer 1 (20 mmol/L Tris-
HCl, pH 7.5; 5 mmol/L MgCl2; 100 mmol/L KCl; 5
mmol/L 2-mercaptoethanol; 250 mmol/L sucrose) sup-
plemented with Triton X-100 (1%), cyclohexamide (150

g/mL) and RNasin (100 u/mL; CinnaGen, Vancouver,
Canada). The samples were transferred to a cold glass
dounce homogenizer (7 mL) and lysed with 40 strokes.
The homogenates then were transferred to a polypropylene
tube, and the volume was brought to 4 mL with buffer 1
and centrifuged at 12000g for 15 minutes at 4° C in a
Beckman ultracentrifuge with a JA-20 rotor (Fullerton,
Calif).
The resultant postmitochondrial supernatant then was
layered over a cold 1-mol/L sucrose cushion (4 mL) and
centrifuged at 260,000g for 2 hours at 4° C with a Beck-
man fixed angle 70.1 Ti rotor. The supernatant was dis-
carded, and the resultant polysome pellet was stored at
80° C for further analysis.
Densitometry. Autoradiographs were scanned and
then quantitatively analyzed with NIH Image 1.60. Differ-
ences in band intensity then were analyzed for statistically
significant differences with a two-tailed t test. Significance
was assumed for P values of .05 or less.
RESULTS
Fluid flow reduces E-selectin protein accumulation
in response to inflammatory agonists. We extended our
previous results5 by showing an inhibitory effect of flow on
E-selectin expression induced with a variety of inflamma-
tory agonists. Confluent HUVEC monolayer cultures were
treated for 4 hours with various agonists known to induce
an inflammatory phenotype in the presence or absence of
fluid flow.14 Immunoblotting for E-selectin protein then
was performed on total cell lysates (Fig 1 , A). TNF-,
interleukin-1, OSM, and phorbol ester (phorbol 12-my-
ristate 13-acetate) all induced E-selectin protein produc-
tion, but in each case, the amount of E-selectin was reduced
by fluid flow. Furthermore, the amount of immunoreactive
E-selectin was reduced by flow at each of several concen-
trations of TNF-, although the inhibitory effect was less
apparent at the highest cytokine concentrations (Fig 1 , B ,
C). Similar results were obtained for increasing concentra-
tions of interleukin-1, phorbol 12-myristate 13-acetate,
and OSM (not shown). All subsequent studies with TNF-
were performed with a dose of 10 u/mL.
The inhibitory effect of flow on E-selectin protein
accumulation was present at all time points studied be-
tween 1 and 24 hours after addition of agonist (Fig 1 , D).
In limited studies with an orbital frequency of 100 rpm
Fig 2. Fluid flow does not inhibit expression of E-selectin mRNA
with HUVEC after stimulation with TNF-. Confluent HUVEC
monolayers were stimulated with TNF- (0 or 10 u/mL) for 1 or
4 hours in the presence or absence of fluid flow (200 rpm).
Ribonuclease protection assays were performed to detect E-selec-
tin or GAPDH mRNA in samples of total cellular RNA isolated
from the monolayers (see Methods). Results are representative of
at least three experiments.
Fig 3. Delayed application of fluid flow inhibits TNF-–induced
E-selectin protein expression in HUVEC. Confluent HUVECs
were treated with TNF- (10 u/mL) for 4 hours under specified
flow conditions. Samples then were processed for Western blot-
ting. No-delay immediate application of fluid flow (200 rpm) with
TNF- stimulation. Delay of 1 hour of fluid flow applied (200
rpm) 1 hour after TNF- stimulation. Results are representative of
three experiments.
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(peak shear stress, 4 dyn/cm2), qualitatively similar re-
ductions in E-selectin protein expression were also seen
(not shown).
We also compared the response produced witrh the
orbital shaker with that produced with a cone-plate viscom-
eter that imposes laminar fluid shear stress on the cultured
HUVEC. Consistent with our previous experience with
other endothelial responses,6 both methods of producing
fluid flow resulted in similar reductions in E-selectin pro-
tein expression (not shown).
Fluid flow does not inhibit total E-selectin mRNA
expression. We then asked whether our previously ob-
served differences in NF-B translocation5 produced par-
allel decreases in E-selectin mRNA that correlated with the
flow-dependent reduction in E-selectin protein accumula-
tion shown in Fig 1. Ribonuclease protection assays were
performed to analyze E-selectin mRNA levels after TNF-
stimulation in the presence or absence of fluid flow. Despite
the inhibitory effect of fluid flow on NF-B translocation5
and E-selectin protein (Fig 1), we observed no flow-depen-
Fig 4. Fluid flow does not induce shedding of E-selectin from endothelial cell surface. A, Confluent HUVEC were
stimulated with TNF- (10 u/mL) for 4 hours in presence or absence of fluid flow (200 rpm). Conditioned medium
(serum-free; see Methods) was collected, and cell layers were prepared for immunoblotting. Samples of conditioned
medium were concentrated with centrifugation in Centricon tube (30,000 D cutoff) before Western blotting. B,
Enzyme-linked immunosorbent assay for soluble E-selectin in samples collected in parallel with those described in A.
Results are representative of duplicate experiments.
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dent differences in levels of E-selectin mRNA after stimu-
lation with TNF- (Fig 2). Levels of E-selectin mRNA after
TNF- stimulation were equivalent at both 1 and 4 hours
after stimulation in both static control cultures and those
cultures exposed to fluid flow. These findings indicate that
the inhibitory effect of fluid flow on NF-B activation5 is
insufficient to prevent E-selectin transcription after stimu-
lation with TNF-. Also, flow-dependent inhibition of
NF-B is unlikely to be responsible for the reduced E-
selectin protein expression seen in HUVEC exposed to
flow.
Application of flow after initiation of transcription
reduces E-selectin protein levels. Because flow had no
effect on E-selectin mRNA levels, we hypothesized that its
inhibitory effect on E-selectin protein expression was being
exerted on a posttranscriptional level. If this were true, the
inhibitory effect of flow on E-selectin protein levels should
be apparent even if application of flow were delayed until
E-selectin transcription had already been initiated. E-selec-
tin mRNA transcripts are readily apparent 1 hour after
TNF- stimulation (Fig 2). E-selectin protein accumula-
tion was still inhibited even if the onset of fluid flow was
delayed by 1 hour after TNF- stimulation (Fig 3), consis-
tent with an effect downstream of transcription.
Fluid flow does not cause E-selectin to be shed. We
next explored mechanisms with which fluid flow might
reduce E-selectin protein levels through posttranscriptional
regulation. E-selectin can be shed from the cell surface, and
serum levels of soluble E-selectin have been proposed as a
marker of endothelial activation.15 To test the possibility
that fluid flow causes E-selectin to be shed from the cell and
thereby reduces accumulated protein in the whole cell
lysate, we assayed E-selectin in the conditioned medium
(serum-free; see Methods) of TNF-stimulated HUVEC
cultures with both an enzyme-linked immunosorbent assay
that detects soluble E-selectin and immunoblotting (Fig
4). These analyses showed the expected inhibitory effect of
flow on E-selectin protein levels, but no E-selectin was
detected in the culture medium. This result indicates that
flow-induced shedding is not the mechanism with which
E-selectin protein accumulation in endothelial cells is re-
duced.
Fluid flow does not accelerate E-selectin degrada-
tion. It is also possible that proteolysis is activated by fluid
flow so that E-selectin degradation occurs more rapidly
under flow compared with static conditions. We tested this
possibility with a pulse chase experiment (Fig 5). Endothe-
lial cells were stimulated under static conditions with
TNF- in the presence of [35S]methionine to label E-
selectin. The medium then was changed, and the cells were
either kept static or exposed to flow. If flow specifically
activated a proteolytic process targeting E-selectin, samples
from endothelial cells exposed to flow should contain less
labeled E-selectin than the static samples. However, the
amount of radioactivity recovered with immunoprecipitat-
ing the samples with an E-selectin antibody was the same in
both the static and sheared samples at both 4 and 6 hours,
indicating that E-selectin was metabolized at the same rate
in both the sheared and static samples. These data argue
against the induction of a proteolytic pathway for E-selectin
by fluid flow.
Fluid flow inhibits incorporation of E-selectin
mRNA into polyribosomes. The experiments in Figs 4
and 5 indicated that a posttranslational process was not
responsible for the flow-dependent decrease in E-selectin
protein levels. We next investigated whether translation of
E-selectin mRNA is regulated by flow. Monolayer HUVEC
cultures were stimulated with TNF- in the presence or
absence of fluid shear. Parallel endothelial cultures from the
same umbilical cord then were processed for analysis of
total E-selectin mRNA and for E-selectin mRNA specifi-
cally associated with polyribosomes (Fig 6). Consistent
with our earlier results (Fig 2), the amount of total E-
selectin mRNA was unaffected by fluid flow (compare lanes
2 and 3). However, the amount of E-selectin mRNA
recovered in the polysome fraction from endothelial cells
subjected to flow was markedly reduced compared with
that recovered from the static control endothelial cultures
(compare lanes 5 and 6). In contrast, fluid flow did not
reduce the amount of GAPDH message in polysomes.
Fig 5. Fluid flow does not alter E-selectin degradation. Pulse-chase experiment was performed in presence or absence
of fluid flow. Pulse: confluent HUVECs were stimulated with TNF- (10 u/mL) for 4 hours at static flow conditions
in [35S]methionine-containing medium (1 106 Bq/mL). Chase: medium then was replaced with complete medium,
and cultures were kept static or subjected to fluid flow (200 rpm) for indicated time (4 or 6 hours). Labeled E-selectin
then was immunoprecipitated and processed for gel autoradiography (see Methods).
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These data indicate that translation of E-selectin mRNA
molecules is under a specific type of negative regulation
induced by fluid flow because not all mRNA species were
similarly affected.
To ensure that fluid flow was not producing a global
decrease in protein synthesis, we compared [35S]methi-
onine incorporation by HUVEC exposed to fluid flow
versus static flow (Fig 6 , B). These results indicate that the
predominant response by HUVEC exposed to fluid flow is
to increase overall protein synthesis and further highlight
the specificity of reduced expression of E-selectin.
DISCUSSION
We hypothesized that the endothelial response to an
inflammatory agonist would be altered by the biomechani-
cal environment, specifically by the presence of simulated
blood flow. After stimulation with TNF-, we observed a
consistent decrease in E-selectin protein expression by en-
dothelial cells exposed to fluid flow when compared with
cultures incubated under static conditions. We then evalu-
ated the effect of flow on critical intracellular events that
regulate E-selectin expression. Although the reduction in
E-selectin protein expression was consistent with our pre-
vious findings that flow inhibited NF-B nuclear transloca-
tion,5 no difference was observed in total cellular E-selectin
mRNA levels. We thus concluded that fluid flow regulates
E-selectin protein production at a posttranscriptional step.
The finding that application of flow after initiation of
transcription still decreased E-selectin protein in combina-
tion with the finding that fluid flow inhibited incorporation
of E-selectin mRNA into polyribosomes suggests that flow
independently and specifically restricts access of the E-
selectin mRNA transcript to the translational apparatus.
Our findings suggest new mechanisms with which
blood flow may modulate inflammatory events in vivo.
Atherosclerosis, a vascular manifestation of chronic inflam-
mation, is less pronounced in regions of the circulation
where high flows and shear stresses exist.16 Leukocyte-
endothelial interactions must be more avid to withstand the
shearing forces in the normal circulation and therefore are
less likely to occur in larger vessels compared with the
low-shear postcapillary venules. Flow also induces re-
sponses in endothelial cells that are generally antiinflamma-
tory in nature, such as upregulation of nitric oxide and
prostacyclin. In this report, we describe a novel mechanism
with which fluid flow exerts an antiinflammatory effect:
inhibition of E-selectin protein synthesis at the translational
level.
To date, most studies of the effect of flow on endothe-
lial function have focused on transcriptional or pretran-
scriptional events.17 There are several reasons why post-
transcriptional or translational regulation with fluid flow is
biologically advantageous. Direct translational control al-
lows a cell to respond to a change in its environment more
rapidly than if transcription of new mRNA is required to
adapt to the change. Even when a response, such as induc-
tion of E-selectin, is transcription dependent, additional
regulation of this biologically critical protein at the point of
translation allows greater precision or “editing” of the cell’s
response to the stimulus. Further, modulation by flow
allows endothelial cells to respond to inflammatory signals
in a tissue-specific manner that may not be available to cells
in extravascular compartments.
We contend that access of E-selectin’s transcript to the
translational apparatus is being regulated by fluid flow in
some specific way and not occurring as a result of a global
decrease in the overall translational activity of the cell. Two
findings support this view. First, overall protein synthetic
Fig 6. Fluid flow reduces polysome-associated E-selectin mRNA
despite overall increase in protein synthesis. A, HUVEC monolay-
ers were stimulated with TNF- (10 u/mL) for 4 hours in pres-
ence or absence of fluid flow (200 rpm). Parallel cultures then were
processed for isolation of total cellular RNA or polysome-associ-
ated RNA (see Methods). Ribonuclease protection assay then was
performed to detect E-selectin and GAPDH mRNA. Results are
representative of duplicate experiments. B, HUVEC monolayers
were metabolically labeled with [35S]methionine for 4 hours in
presence or absence of fluid flow. Cell lysates then were resolved
with SDS-PAGE and processed for autoradiography. Results are
representative of at least three experiments.
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activity appears to be increased by fluid flow (Fig 6 , B).
Second, the amount of GAPDH mRNA present in the
polysome fraction was unaffected by flow. GAPDH, a
“housekeeping gene,” has not been found to be subject to
translational control in other cell types.18,19 In preliminary
experiments with a microarray strategy specifically designed
to detect genes subject to translational control,20 we found
no evidence that GAPDH protein expression in HUVEC
treated with a variety of agonists is subject to separate
translational control21 (Schmid DI, Kraiss LW, unpub-
lished data, 2002). Regulation of translation typically oc-
curs at the point of initiation because it is most economic to
regulate such an energy-consuming process at its first
step.22 Because the effect of flow appears to be specific
rather than global, the regulatory mechanism is likely to
arise from some characteristic of the E-selectin mRNA.
One possibility is the existence of a cis regulatory element in
the 5 or 3 untranslated regions of the E-selectin transcript
that interacts with a flow-activated transacting protein re-
stricting the transcript’s access to the polysome. Inspection
of the 5 untranslated region of the E-selectin mRNA14
reveals a region that is predicted to form a stem-loop
secondary structure that is a common motif for interactions
with transacting regulatory proteins.22,23 In summary, the
findings in this report, and our recent observation that fluid
flow modulates key translational control enzymes in endo-
thelial cells,6 broaden the range of mechanisms with which
hemodynamic forces may regulate gene expression in vas-
cular cells.
We thank Tina M. Ennis for careful and capable tech-
nical assistance.
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